Common Contracts
1 similar Strategic Collaboration and License Agreement contracts
INNOVENT AND UNION THERAPEUTICS ENTER INTO STRATEGIC COLLABORATION AND LICENSE AGREEMENT FOR ORISMILAST, A NEXT-GENERATION PDE4 INHIBITOR FOR INFLAMMATORYStrategic Collaboration and License Agreement • April 13th, 2019
This announcement is made by Innovent Biologics, Inc. (the “Company”, together with its subsidiaries, the “Group”) on a voluntary basis to inform the shareholders and potential investors of the Company about the latest business updates of the Group.
